243 related articles for article (PubMed ID: 4837833)
1. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
Nilsson O; Nygren KG
Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
[TBL] [Abstract][Full Text] [Related]
2. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
Nygren KG; Johansson ED; Wide L
Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
[TBL] [Abstract][Full Text] [Related]
3. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
4. Postovulatory contraception in women with large doses of norethindrone.
Nygren KG; Johansson ED; Wide L
Contraception; 1972 Jun; 5(6):445-56. PubMed ID: 4650660
[TBL] [Abstract][Full Text] [Related]
5. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
6. Subdermal norethindrone pellets -- a method for contraception?
Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
8. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
Song S; Chen JK; Lu CH; Yang PJ; Yang QY; Fan BC; He ML; Gui YL; Li LM; Fotherby K
Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
[TBL] [Abstract][Full Text] [Related]
9. Endometrial changes induced by the administration of an oral contraceptive, norethindrone (S-3800B).
Utsumi K; Kuribayashi N; Kumakiri S
Acta Pathol Jpn; 1966 May; 16(2):141-50. PubMed ID: 6012525
[TBL] [Abstract][Full Text] [Related]
10. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
11. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
Meng YX; Virutamasen P
Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
[TBL] [Abstract][Full Text] [Related]
12. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill.
Johannisson E; Landgren BM; Diczfalusy E
Contraception; 1982 Jan; 25(1):13-30. PubMed ID: 7060371
[No Abstract] [Full Text] [Related]
13. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
14. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
15. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
16. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
Souka AR; Kamel M; Einen MA; Saleh F; Sallam H
Contraception; 1985 Jun; 31(6):571-81. PubMed ID: 3899504
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
[TBL] [Abstract][Full Text] [Related]
19. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
Weikel JH; Nelson LW
J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
[TBL] [Abstract][Full Text] [Related]
20. The relative expressed estrogenicity of oral contraceptives.
Rooks WH; Kugler SL; Dorfman RI
Fertil Steril; 1968; 19(3):419-23. PubMed ID: 5647620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
